USD 553 Mil as of today(2019-12-15). In depth view into IDEXX Laboratories EBIT explanation, calculation, historical data and more" />IDXX EBIT | IDEXX Laboratories - GuruFocus.com
Switch to:

IDEXX Laboratories EBIT

: USD 553 Mil (TTM As of Sep. 2019)
View and export this data going back to 1991. Start your Free Trial

IDEXX Laboratories's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2019 was USD 140 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2019 was USD 553 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. IDEXX Laboratories's annualized ROC % for the quarter that ended in Sep. 2019 was 41.62%. IDEXX Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2019 was 73.54%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. IDEXX Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 was 2.28%.

IDEXX Laboratories EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

IDEXX Laboratories Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.98 302.38 353.90 418.28 492.49

IDEXX Laboratories Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.49 115.61 133.18 164.31 139.89

IDEXX Laboratories EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then operating income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was 115.605 (Dec. 2018 ) + 133.178 (Mar. 2019 ) + 164.308 (Jun. 2019 ) + 139.888 (Sep. 2019 ) = USD 553 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

IDEXX Laboratories  (NAS:IDXX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

IDEXX Laboratories's annualized ROC % for the quarter that ended in Sep. 2019 is calculated as:

ROC %(Q: Sep. 2019 )
=NOPAT/Average Invested Capital
=Operating Income*(1-Tax Rate)/( (Invested Capital (Q: Jun. 2019 ) + Invested Capital (Q: Sep. 2019 ))/2)
=559.208 * ( 1 - 18.04% )/( (1096.815 + 1105.699)/2)
=458.3268768/1101.257
=41.62 %

where

Invested Capital(Q: Jun. 2019 )
=Book Value of Debt + Book Value of Equity - Cash
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation + Total Stockholders Equity - Cash
=769.883 + 266.531 + 171.246 - 110.845
=1096.815

Invested Capital(Q: Sep. 2019 )
=Book Value of Debt + Book Value of Equity - Cash
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation + Total Stockholders Equity - Cash
=762.975 + 244.302 + 202.418 - 103.996
=1105.699

Note: The Operating Income data used here is four times the quarterly (Sep. 2019) operating income data.

2. Joel Greenblatt's definition of Return on Capital:

IDEXX Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2019 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2019 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2019  Q: Sep. 2019
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/2 )
=559.552/( ( (551.537 + max(213.323, 0)) + (575.561 + max(181.308, 0)) )/2 )
=559.552/( ( 764.86 + 756.869 )/2 )
=559.552/760.8645
=73.54 %

where Working Capital is:

Working Capital(Q: Jun. 2019 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(286.154 + 196.876 + 82.671) - (222.871 + 43.446 + 86.061)
=213.323

Working Capital(Q: Sep. 2019 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(268.319 + 204.893 + 90.421) - (240.982 + 42.986 + 98.357)
=181.308

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2019) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

IDEXX Laboratories's Earnings Yield (Joel Greenblatt) %for the quarter that ended in Sep. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2019 )
=552.979/24259.6527
=2.28 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

IDEXX Laboratories EBIT Related Terms

IDEXX Laboratories EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */